.
breaking news emails
.
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.i know major media won�t investigate medically-caused death numbers, because i�ve published reports for years, and i�ve contacted news people with the facts; and nothing happens..
.
.
.
ai-based software may help predict risk of dementia.